Efficacy and safety of dasatinib vs. Imatinib in Latin american subpopulation from the dasision trial in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP)

Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/353193

Type:	Outro documento
Title:	Efficacy and safety of dasatinib vs. Imatinib in Latin american subpopulation from the dasision trial in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP)
Author:	Enrico, A. Milone, J. Moiraghi, B. Casanova, L. Undurraga, M. S. Olivera, L. Enciso Bullorsky, E. Navarro Cabrera, J. Pagnano, K. De Riz, M. Pavlovsky, C.
Abstract:	sem informação
Subject:	Leucemia mielóide crônica
Country:	Itália
Editor:	Fondazione Ferrata StortiFondazione Ferrata Storti
Rights:	Aberto
Address:	https://haematologica.org/issue/view/284
Date Issue:	2015
Appears in Collections:	HEMO - Artigos e Outros Documentos

Files in This Item:

File	Description	Size	Format
000361204903101.pdf		285.21 kB	Adobe PDF	View/Open